139 related articles for article (PubMed ID: 31036559)
1. Impact of Phosphodiesterase 4 Inhibition on the Operational Efficacy, Response Maxima, and Kinetics of Indacaterol-Induced Gene Expression Changes in BEAS-2B Airway Epithelial Cells: A Global Transcriptomic Analysis.
Joshi R; Yan D; Hamed O; Mostafa MM; Joshi T; Newton R; Giembycz MA
Mol Pharmacol; 2019 Jul; 96(1):56-72. PubMed ID: 31036559
[TBL] [Abstract][Full Text] [Related]
2. GS-5759, a Bifunctional β2-Adrenoceptor Agonist and Phosphodiesterase 4 Inhibitor for Chronic Obstructive Pulmonary Disease with a Unique Mode of Action: Effects on Gene Expression in Human Airway Epithelial Cells.
Joshi T; Yan D; Hamed O; Tannheimer SL; Phillips GB; Wright CD; Kim M; Salmon M; Newton R; Giembycz MA
J Pharmacol Exp Ther; 2017 Feb; 360(2):324-340. PubMed ID: 27927912
[TBL] [Abstract][Full Text] [Related]
3. Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.
Tannheimer SL; Wright CD; Salmon M
Respir Res; 2012 Mar; 13(1):28. PubMed ID: 22452977
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the Adverse and Therapeutic Effects of
Yan D; Hamed O; Joshi T; Mostafa MM; Jamieson KC; Joshi R; Newton R; Giembycz MA
J Pharmacol Exp Ther; 2018 Jul; 366(1):220-236. PubMed ID: 29653961
[TBL] [Abstract][Full Text] [Related]
5. Phosphodiesterase 4 inhibitors augment the ability of formoterol to enhance glucocorticoid-dependent gene transcription in human airway epithelial cells: a novel mechanism for the clinical efficacy of roflumilast in severe chronic obstructive pulmonary disease.
Moodley T; Wilson SM; Joshi T; Rider CF; Sharma P; Yan D; Newton R; Giembycz MA
Mol Pharmacol; 2013 Apr; 83(4):894-906. PubMed ID: 23389862
[TBL] [Abstract][Full Text] [Related]
6. Superiority of combined phosphodiesterase PDE3/PDE4 inhibition over PDE4 inhibition alone on glucocorticoid- and long-acting β2-adrenoceptor agonist-induced gene expression in human airway epithelial cells.
BinMahfouz H; Borthakur B; Yan D; George T; Giembycz MA; Newton R
Mol Pharmacol; 2015 Jan; 87(1):64-76. PubMed ID: 25324049
[TBL] [Abstract][Full Text] [Related]
7. Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells.
Tannheimer SL; Sorensen EA; Haran AC; Mansfield CN; Wright CD; Salmon M
Pulm Pharmacol Ther; 2012 Apr; 25(2):178-84. PubMed ID: 22306235
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of long-acting β
Kim Y; Hou V; Huff RD; Aguiar JA; Revill S; Tiessen N; Cao Q; Miller MS; Inman MD; Ask K; Doxey AC; Hirota JA
Respir Res; 2021 Oct; 22(1):266. PubMed ID: 34666750
[TBL] [Abstract][Full Text] [Related]
9. Hybrids consisting of the pharmacophores of salmeterol and roflumilast or phthalazinone: dual β₂-adrenoceptor agonists-PDE4 inhibitors for the treatment of COPD.
Liu A; Huang L; Wang Z; Luo Z; Mao F; Shan W; Xie J; Lai K; Li X
Bioorg Med Chem Lett; 2013 Mar; 23(5):1548-52. PubMed ID: 23375225
[TBL] [Abstract][Full Text] [Related]
10. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
11. Roflumilast, indacaterol maleate, and abiraterone acetate.
Hussar DA; DePasquale J
J Am Pharm Assoc (2003); 2011; 51(5):668-71. PubMed ID: 21896467
[No Abstract] [Full Text] [Related]
12. The in vitro pharmacology of GS-5759, a novel bifunctional phosphodiesterase 4 inhibitor and long acting β2-adrenoceptor agonist.
Tannheimer SL; Sorensen EA; Cui ZH; Kim M; Patel L; Baker WR; Phillips GB; Wright CD; Salmon M
J Pharmacol Exp Ther; 2014 Apr; 349(1):85-93. PubMed ID: 24513870
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome-Level Interactions between Budesonide and Formoterol Provide Insight into the Mechanism of Action of Inhaled Corticosteroid/Long-Acting
Mostafa MM; Rider CF; Wathugala ND; Leigh R; Giembycz MA; Newton R
Mol Pharmacol; 2021 Mar; 99(3):197-216. PubMed ID: 33376135
[TBL] [Abstract][Full Text] [Related]
14. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD.
Milara J; Peiró T; Serrano A; Guijarro R; Zaragozá C; Tenor H; Cortijo J
Pulm Pharmacol Ther; 2014 Aug; 28(2):138-48. PubMed ID: 24525294
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid Receptor α Mediates Roflumilast's Ability to Restore Dexamethasone Sensitivity in COPD.
Reddy AT; Lakshmi SP; Banno A; Reddy RC
Int J Chron Obstruct Pulmon Dis; 2020; 15():125-134. PubMed ID: 32021151
[TBL] [Abstract][Full Text] [Related]
16. The long-acting β2 -adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner.
Joshi T; Johnson M; Newton R; Giembycz MA
Br J Pharmacol; 2015 May; 172(10):2634-53. PubMed ID: 25598440
[TBL] [Abstract][Full Text] [Related]
17. Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro.
Milara J; Armengot M; Bañuls P; Tenor H; Beume R; Artigues E; Cortijo J
Br J Pharmacol; 2012 Aug; 166(8):2243-62. PubMed ID: 22385203
[TBL] [Abstract][Full Text] [Related]
18. Prostanoid Receptors of the EP
Joshi R; Hamed O; Yan D; Michi AN; Mostafa MM; Wiehler S; Newton R; Giembycz MA
J Pharmacol Exp Ther; 2021 Feb; 376(2):161-180. PubMed ID: 33158942
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
20. Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposure.
Tyrrell J; Qian X; Freire J; Tarran R
Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(10):L1068-77. PubMed ID: 25795727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
